Novartis (NVS) operating margin

Operating margin · fiscal 2025
31.1%

Novartis (NVS) had an operating margin of 31.1% in fiscal 2025 (the year ended December 31, 2025). That is 3.0 percentage points higher than the 28.1% of fiscal 2024. Figures as of 17 Nov 2026, 21:23 UTC, from Yahoo Finance.

Key facts

Operating margin, fiscal 2025
31.1%
Change on fiscal 2024
+3.0 pts
Highest on record
31.1%fiscal 2025
Lowest on record
18.3%fiscal 2022
Fiscal years on record
42022–2025

Figures as of . Statements from Yahoo Finance. Figures, not advice.

Novartis operating margin, in more detail

Across the 4 fiscal years on record (2022–2025), the highest was 31.1% in fiscal 2025 and the lowest 18.3% in fiscal 2022. The fiscal 2025 figure is higher than in every one of the 3 earlier fiscal years on record, whose median is 20.9%.

Gross margin was 75.8% in fiscal 2025. Net margin was 24.7% in fiscal 2025.

History · 4 fiscal years

Operating margin by fiscal year

  • Operating margin
  • Gross margin
  • Net margin

Novartis operating margin, year by year

Novartis (NVS) operating margin by fiscal year
Fiscal yearOperating marginChangeYear endedGross marginNet margin
202531.1% 3.0 pts up75.8%24.7%
202428.1% 7.2 pts up75.2%23.1%
202320.9% 2.7 pts up73.3%31.8%
202218.3%—73.4%16.0%

Change is on the fiscal year before, in percentage points; a dash means that year is not on record. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Operating margin is operating income divided by revenue; gross margin does the same with gross profit, and net margin with net income.

How to read it

It shows how much of each unit of sales survives the cost of running the business — rising margins point to pricing power or scale, falling ones to pressure.

Operating margin at health care companies of similar size

Operating margin of Novartis and comparable companies
CompanyOperating marginFiscal year
AbbVie ABBV32.8%2025
Merck & Co MRK34.0%2025
UnitedHealth Group UNH4.2%2025
Novartis NVS31.1%2025
AstraZeneca AZN22.7%2025
Thermo Fisher Scientific TMO18.2%2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on NVS

Novartis, figure by figure

Novartis (NVS) overview: price, valuation and scorecardAll health care companies by market value

Novartis operating margin: questions and answers

What is Novartis's operating margin?

Novartis (NVS) had an operating margin of 31.1% in fiscal 2025 (the year ended December 31, 2025). That is 3.0 percentage points higher than the 28.1% of fiscal 2024.

Is Novartis's operating margin high or low compared with its own history?

The fiscal 2025 figure is higher than in every one of the 3 earlier fiscal years on record, whose median is 20.9%.

What are the highest and lowest operating margin figures on record for Novartis?

Across the 4 fiscal years on record (2022–2025), the highest was 31.1% in fiscal 2025 and the lowest 18.3% in fiscal 2022.

What are Novartis's gross and net margins?

Gross margin was 75.8% in fiscal 2025. Net margin was 24.7% in fiscal 2025.

How is Novartis's operating margin calculated?

Operating margin is operating income divided by revenue; gross margin does the same with gross profit, and net margin with net income.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Novartis (NVS) operating margin”, data as of 17 November 2026. https://funkfolio.com/stock/NVS/operating-margin

Underlying data: Yahoo Finance.